The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder / Ronald N. Marcus en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 2 (Abril) . - pp. 156-165 Título : The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder : A second multicenter, randomized, double-blind, placebo-controlled study Tipo de documento: texto impreso Autores: Ronald N. Marcus, Autor ; Robert D. McQuade, Autor ; William H. Carson, Autor Fecha de publicación: 2023 Artículo en la página: pp. 156-165 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Acatisia inducida por fármacos, Antidepresivos, Citalopram, Trastorno depresivo mayor, Terapia con medicamentos, Fatiga, Paroxetina, Piperazinas, Sertralina, Aumento de peso - efectos del medicamento. Resumen: Nonresponse to one or more antidepressants is common and an important public health problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to standard antidepressant therapy (ADT) in patients with major depressive disorder who showed an inadequate response to at least 1 and up to 3 historical and 1 additional prospective ADT. Link: ./index.php?lvl=notice_display&id=30858 [artículo] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder : A second multicenter, randomized, double-blind, placebo-controlled study [texto impreso] / Ronald N. Marcus, Autor ; Robert D. McQuade, Autor ; William H. Carson, Autor . - 2023 . - pp. 156-165. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 2 (Abril) . - pp. 156-165 Palabras clave: Acatisia inducida por fármacos, Antidepresivos, Citalopram, Trastorno depresivo mayor, Terapia con medicamentos, Fatiga, Paroxetina, Piperazinas, Sertralina, Aumento de peso - efectos del medicamento. Resumen: Nonresponse to one or more antidepressants is common and an important public health problem. This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to standard antidepressant therapy (ADT) in patients with major depressive disorder who showed an inadequate response to at least 1 and up to 3 historical and 1 additional prospective ADT. Link: ./index.php?lvl=notice_display&id=30858

---

1 (1 - 1 / 1)